Recent Updates
Recently added Catalysts
FULC Positive Sentiment

Fulcrum Therapeutics to Host Second Quarter 2023 Financial Results Conference Call and Webcast on Thursday, August 3, 2023, at 8:00 a.m. ET

Thursday, July 27, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Fulcrum Therapeutics, a clinical-stage biopharmaceutical company, will release its second quarter 2023 financial results on August 3, 2023. The company will conduct a conference call and webcast to discuss these results and provide updates on corporate developments. Interested individuals can register for the call to access dial-in details and will also have the option to listen to an archived replay after the event.
Price reaction · baseline $3.72 (2023-07-26 close) · hit after-hours · clean, no other FULC news in the window
day 0 close · peak
-4.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Fulcrum Therapeutics is set to release its Q2 2023 financial results, signaling transparency.
  • The company is focused on addressing genetically defined rare diseases, highlighting its commitment to improving patient lives.
  • The management will provide an update on recent corporate developments, promising additional insights.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
15.6%
average across 6 past catalysts
Cash runway
~59 mo
Minimal dilution risk
Lead asset
Pociredir
Phase 2 · Sickle Cell Disease

Full Press Release Details

CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that its second quarter 2023 financial results will be released on Thursday, August 3, 2023 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.
Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and unique PIN which will allow them to access the call. An audio webcast will be accessible through the Investor Relations section of the company’s website at www.fulcrumtx.com or by clicking here. Following the live webcast, an archived replay will also be available.
About Fulcrum Therapeutics
LifeSci Advisors, LLC
ccalabrese@lifesciadvisors.com
Executive Director, Corporate Communications
Fulcrum Therapeutics, Inc.

Frequently Asked Questions

When will Fulcrum Therapeutics release its Q2 2023 financial results?

Fulcrum Therapeutics will release its Q2 2023 financial results on August 3, 2023.

What time is the conference call scheduled for?

The conference call will take place at 8:00 a.m. ET on August 3, 2023.

How can individuals join the conference call?

Individuals can register through the provided link to receive dial-in details.

Where can I find the audio webcast of the call?

The audio webcast will be accessible on the Investor Relations section of their website.

Will there be a replay of the conference call available?

Yes, an archived replay of the conference call will be available after the live event.

ShareAdd on Google
Tags: FULC Viatris Investor Conferences Healthcare financial results biopharmaceutical rare diseases conference call
Last updated: Jul 27, 2023

Biotech snapshot

Cash runway
$319M liquidity · $5M/mo burn
~59 mo
Minimal dilution risk
Lead asset
PociredirPhase 2
Sickle Cell Disease →

Catalyst track record

+32%
best trade around FULC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for FULC.

See every catalyst's timing & PoA →